Document Detail

Obstetrical Opportunities: Will Pharmacy Ever Realize Them? (February).
MedLine Citation:
PMID:  22298603     Owner:  NLM     Status:  Publisher    
Based on a survey of the American College of Clinical Pharmacy Women's Health Practice and Research Network and our own experience, the pharmacy profession has limited involvement in obstetric pharmacotherapy. We believe that such involvement in pregnancies with complicated conditions can result in significant improvement of pregnancy outcomes. Moreover, we believe thisinvolvement would be welcomed by the physicians caring for these patients. This commentary documents current obstetrical pharmacy practices and proposes changes for the profession of pharmacy to consider.
Denise Ragland; Gerald G Briggs; Mitzi Wasik; Julie J Kelsey; Ema Ferreira; Wendy Abe-Fukushima; Alicia B Forinash; Brenda D Kelly; Michael P Nageotte
Related Documents :
25267163 - Cumulative live birth rate after two single frozen embryo transfers (esfet) versus a do...
17085773 - Safety and efficacy of black cohosh (cimicifuga racemosa) during pregnancy and lactation.
18279493 - Ultrastructural morphology of platelets and fibrin networks of lactating and non-pregna...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-1-31
Journal Detail:
Title:  The Annals of pharmacotherapy     Volume:  -     ISSN:  1542-6270     ISO Abbreviation:  -     Publication Date:  2012 Jan 
Date Detail:
Created Date:  2012-2-2     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9203131     Medline TA:  Ann Pharmacother     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Department of Pharmacy Practice, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tesamorelin: A Growth Hormone-Releasing Factor Analogue for HIV-Associated Lipodystrophy (February).
Next Document:  Serum Potassium Influencing Interacting Drugs: Risk-Modifying Strategies Also Needed at Discontinu...